Dublin, Ohio-based Cardinal Health has agreed to pay $8 million to resolve claims that it made payments to induce referral orders for its prescription drugs, according to a Department of Justice news release.
The case alleged that Cardinal Health violated the False Claims Act and Anti-Kickback Statute. It was filed by two whistleblowers: pharmacy owner R. Daniel Saleaumua and pharmacy consultant Kevin Rinne. Mr. Saleaumua alleged that Cardinal paid him $440,000 in exchange for purchasing Cardinal drugs.
Together, Mr. Saleaumua and Mr. Rinne will receive $760,000 of the settlement.
Read the DOJ release on Cardinal Health’s settlement.
Read about other pharmaceutical companies involved in lawsuits:
– CVS Pays $17M To Settle Medicaid Fraud Allegations
– Harvard Drug Group Pays $8M to Settle Claims of Failure to Report Suspicious Drug Orders
– Bristol-Myers Accused of Kickbacks, Bribing Physicians With Gifts
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.